Zoic Capital
Adrian Berliner is currently the Head of Due Diligence at Zoic Capital, a venture fund focusing on impactful life sciences technologies. Adrian also holds the position of Venture Partner at the same company. Previously, Adrian worked as a Venture Analyst at Zoic Capital. Adrian has experience as a Scientific Advisor at Creative Destruction Lab and as an Investor at ChromaTan, Inc. In addition, Adrian has a background in project consulting and research roles in various organizations. Adrian holds a Master of Science degree in Chemical Biology from Harvard University and a Bachelor's degree in Biochemistry from California State University, Los Angeles.
This person is not in any teams
This person is not in any offices
Zoic Capital
Zoic Capital is the only US-based venture firm focused on early-stage healthcare innovations at the intersection of life sciences and medical technology.Promising Scientific Advancements:We look for breakthroughs with the potential for broad IP and commercial-readymaturity. We invest in roadmaps that leverage a core innovation across manyapplications and industries.Focus on Life Sciences:We see the most exciting advancements coming from life sciences labs, becomingtools that maintain and treat our health. We look at both technologies that enabledevelopment and care delivery devices.We Follow the Numbers:We follow our gut, but we also reinforce each of our decisions with numbers. Webelieve that merging qualitative and quantitative analysis is the best way to makesuccessful investment decisions.Mentored Capital:We have the skills, experience and network to help, working closely with selectteams to transform research into high impact, market-ready products.Milestone-Based Investing:We craft unique deal structures for each portfolio company based on mutually defined milestones. We find this approach creates ongoing momuntum and sets usall up for success.